New Microarray-On-A-Chip Test For Cystic Fibrosis
Originally posted in Cystic Fibrosis News From Medical News Today
Astra Biotech GmbH is in the pre-launch phase of its newly developed test, based on microarray technology, for rapid simultaneous detection of 25 of the most common mutations causing cystic fibrosis in pan-European populations. This initiative supports Astra Biotech’s aim of facilitating early diagnosis of individuals’ risk factors through innovative assays…
by Raelene
